Skip to main content

mdprostate

Product Description

FACILITATES THE DIAGNOSTIC PROCESS AND GIVES YOU PEACE OF MIND.

mdprostate helps radiologists and urologists come to informed conclusions and make the best treatment decisions when assessing prostate carcinoma.

The AI-based tool provides a fully-automated lesion classification according to PI-RADS 2.1 and is fully integrated with all PACS systems. In less than 3 minutes, users receive a report with additional quantitative parameters (e.g. prostate volume), as well as a schematic representation of all lesions on a sector map.

Vendor Info

mediaire GmbH

mediaire GmbH

Möckernstraße 63
10965 Berlin

<< return to products